BRITISH DRUG MANUFACTURER SHIRE has confirmed it received a C$266m (£146m) tax rebate from the Canadian tax authority, with a further C$174m yet to come.
Subject of a takeover bid from Canadian rival AbbVie, the windfall bolstered Shire’s position as it prepares to woo shareholders over the bid.
Shares in the FTSE100 company rose with the news, but started today down 17p at 4,553p per share, Accountancy Age‘s share price centre shows.
The company said on its website: “Shire intends to use the cash receipts to repay debt, providing Shire with increased capacity to invest in focussed business development activities.”
Paul Boyle is appointed as the president of the Chartered Institute of Internal Auditors
More than 5,000 restaurant companies are at risk of insolvency as Brexit raises costs
Three new partners have been appointed at top ten firm BDO
An examination by the Public Accounts Committee (PAC) has revealed serious concerns relating to HMRC’s plans